Boyd M - Search Results

1

Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.

Wolstein O, Boyd M, Millington M, Impey H, Boyer J, Howe A, Delebecque F, Cornetta K, Rothe M, Baum C, Nicolson T, Koldej R, Zhang J, Keech N, Camba Colón J, Breton L, Bartlett J, An DS, Chen IS, Burke B, Symonds GP. Wolstein O, et al. Among authors: boyd m. Mol Ther Methods Clin Dev. 2014 Feb 12;1:11. doi: 10.1038/mtm.2013.11. eCollection 2014. Mol Ther Methods Clin Dev. 2014. PMID: 26015947 Free PMC article.

2

Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.

Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV, Colón JC, Keech N, Rezek V, Bristol G, Eggers E, Cortado R, Boyd MP, Impey H, Shimizu S, Lowe EL, Ringpis GE, Kim SG, Vatakis DN, Breton LR, Bartlett JS, Chen IS, Kitchen SG, An DS, Symonds GP. Burke BP, et al. Mol Ther Nucleic Acids. 2015 Apr 14;4:e236. doi: 10.1038/mtna.2015.10. Mol Ther Nucleic Acids. 2015. PMID: 25872029 Free article.

3

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

Suzuki K, Hattori S, Marks K, Ahlenstiel C, Maeda Y, Ishida T, Millington M, Boyd M, Symonds G, Cooper DA, Okada S, Kelleher AD. Suzuki K, et al. Among authors: boyd m. Mol Ther Nucleic Acids. 2013 Dec 3;2(12):e137. doi: 10.1038/mtna.2013.64. Mol Ther Nucleic Acids. 2013. PMID: 24301868 Free PMC article.

4

Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.

Ledger S, Howe A, Turville S, Aggarwal A, Savkovic B, Ong A, Wolstein O, Boyd M, Millington M, Gorry PR, Murray JM, Symonds G. Ledger S, et al. Among authors: boyd m. J Gene Med. 2018 Feb;20(2-3):e3006. doi: 10.1002/jgm.3006. J Gene Med. 2018. PMID: 29552747

5

The use of cell-delivered gene therapy for the treatment of HIV/AIDS.

Symonds GP, Johnstone HA, Millington ML, Boyd MP, Burke BP, Breton LR. Symonds GP, et al. Immunol Res. 2010 Dec;48(1-3):84-98. doi: 10.1007/s12026-010-8169-7. Immunol Res. 2010. PMID: 20737298 Review.

6

CCR5 as a natural and modulated target for inhibition of HIV.

Burke BP, Boyd MP, Impey H, Breton LR, Bartlett JS, Symonds GP, Hütter G. Burke BP, et al. Viruses. 2013 Dec 30;6(1):54-68. doi: 10.3390/v6010054. Viruses. 2013. PMID: 24381033 Free PMC article.

7

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.

Hütter G, Bodor J, Ledger S, Boyd M, Millington M, Tsie M, Symonds G. Hütter G, et al. Among authors: boyd m. Viruses. 2015 Jul 27;7(8):4186-203. doi: 10.3390/v7082816. Viruses. 2015. PMID: 26225991 Free PMC article. Review.

8

Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.

Ngok FK, Mitsuyasu RT, Macpherson JL, Boyd MP, Symonds GP, Amado RG. Ngok FK, et al. Methods Mol Biol. 2004;252:581-98. doi: 10.1385/1-59259-746-7:581. Methods Mol Biol. 2004. PMID: 15017082 Clinical Trial.

9

Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.

Millington M, Arndt A, Boyd M, Applegate T, Shen S. Millington M, et al. Among authors: boyd m. PLoS One. 2009 Jul 30;4(7):e6461. doi: 10.1371/journal.pone.0006461. PLoS One. 2009. PMID: 19649289 Free PMC article.

10

Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocol.

Boyd MP, Ngok FK, Todd AV, Symonds GP, Macpherson JL, Amado RG. Boyd MP, et al. Methods Mol Biol. 2004;252:599-616. doi: 10.1385/1-59259-746-7:599. Methods Mol Biol. 2004. PMID: 15017083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,584 results

Search Page

Filters